Prosthetic Joint Infections Treatment Market Report

Prosthetic Joint Infections Treatment Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jun 19, 2020
  • PAGES：149
  • REPORT CODE：GMM558568
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Prosthetic Joint Infections Treatment market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.3% during the forecast period.

    This report presents the market size and development trends by detailing the Prosthetic Joint Infections Treatment market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Prosthetic Joint Infections Treatment market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Prosthetic Joint Infections Treatment industry and will help you to build a panoramic view of the industrial development.

    Prosthetic Joint Infections Treatment Market, By Type:

    • Fusidic acid

    • Lefamulin Acetate

    • MTF-101

    • TNP-2092

    • Others

    Prosthetic Joint Infections Treatment Market, By Application:

    • Hospital

    • Clinic

    • Others

    Some of the leading players are as follows:

    • TenNor Therapeutics Ltd

    • Motif Bio Plc

    • Telephus Medical LLC

    • Nabriva Therapeutics AG

    • Cempra Inc

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prosthetic Joint Infections Treatment Market

    • 1.3 Market Segment by Type

      • 1.3.1 Fusidic acid

      • 1.3.2 Lefamulin Acetate

      • 1.3.3 MTF-101

      • 1.3.4 TNP-2092

      • 1.3.5 Others

    • 1.4 Market Segment by Application

      • 1.4.1 Hospital

      • 1.4.2 Clinic

      • 1.4.3 Others

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Prosthetic Joint Infections Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Prosthetic Joint Infections Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Prosthetic Joint Infections Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Prosthetic Joint Infections Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Prosthetic Joint Infections Treatment Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Prosthetic Joint Infections Treatment by Major Types

      • 3.4.1 Fusidic acid

      • 3.4.2 Lefamulin Acetate

      • 3.4.3 MTF-101

      • 3.4.4 TNP-2092

      • 3.4.5 Others

    4 Segmentation of Prosthetic Joint Infections Treatment Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Prosthetic Joint Infections Treatment by Major End-Users

      • 4.4.1 Hospital

      • 4.4.2 Clinic

      • 4.4.3 Others

    5 Market Analysis by Major Regions

    • 5.1 Global Prosthetic Joint Infections Treatment Production Analysis by Top Regions

    • 5.2 Global Prosthetic Joint Infections Treatment Consumption Analysis by Top Regions

    • 5.3 Global Prosthetic Joint Infections Treatment Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Prosthetic Joint Infections Treatment Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Prosthetic Joint Infections Treatment Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Prosthetic Joint Infections Treatment Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Prosthetic Joint Infections Treatment Production, Import, Consumption and Export Analysis

    6 Product Circulation of Prosthetic Joint Infections Treatment Market among Top Countries

    • 6.1 Top 5 Export Countries in Prosthetic Joint Infections Treatment Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Prosthetic Joint Infections Treatment Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Prosthetic Joint Infections Treatment Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Prosthetic Joint Infections Treatment Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Prosthetic Joint Infections Treatment Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Prosthetic Joint Infections Treatment Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Prosthetic Joint Infections Treatment Landscape Analysis

    • 7.1 North America Prosthetic Joint Infections Treatment Landscape Analysis by Top Countries

      • 7.1.1 United States Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 7.1.2 Canada Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 7.1.3 Mexico Prosthetic Joint Infections Treatment Market Volume and Growth Rate

    8. Europe Prosthetic Joint Infections Treatment Landscape Analysis

    • 8.1 Europe Prosthetic Joint Infections Treatment Landscape Analysis by Major Types

    • 8.2 Europe Prosthetic Joint Infections Treatment Landscape Analysis by Major End-Users

    • 8.3 Europe Prosthetic Joint Infections Treatment Landscape Analysis by Top Countries

      • 8.3.1 Germany Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.2 UK Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.3 France Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.4 Italy Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.5 Spain Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.6 Belgium Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.7 Poland Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.8 Russia Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.9 Turkey Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.10 Netherlands Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.11 Portugal Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.12 Denmark Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.13 Finland Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.14 Iceland Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.15 Norway Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 8.3.16 Sweden Prosthetic Joint Infections Treatment Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Prosthetic Joint Infections Treatment Landscape Analysis

    • 9.1 Asia Pacific Prosthetic Joint Infections Treatment Landscape Analysis by Top Countries

      • 9.1.1 China Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 9.1.2 Japan Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 9.1.4 India Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 9.1.5 ASEAN Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 9.1.6 South Korea Prosthetic Joint Infections Treatment Market Volume and Growth Rate

    10 LAMEA Prosthetic Joint Infections Treatment Landscape Analysis

    • 10.1 LAMEA Prosthetic Joint Infections Treatment Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 10.1.2 Brazil Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 10.1.3 North Africa Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 10.1.4 South Africa Prosthetic Joint Infections Treatment Market Volume and Growth Rate

      • 10.1.5 Argentina Prosthetic Joint Infections Treatment Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 TenNor Therapeutics Ltd

      • 11.1.1 TenNor Therapeutics Ltd Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Motif Bio Plc

      • 11.2.1 Motif Bio Plc Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Telephus Medical LLC

      • 11.3.1 Telephus Medical LLC Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Nabriva Therapeutics AG

      • 11.4.1 Nabriva Therapeutics AG Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Cempra Inc

      • 11.5.1 Cempra Inc Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 119 Figures and 144 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Fusidic acid

    • Figure Market Size and Growth Rate of Lefamulin Acetate

    • Figure Market Size and Growth Rate of MTF-101

    • Figure Market Size and Growth Rate of TNP-2092

    • Figure Market Size and Growth Rate of Others

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Others

    • Figure North America Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure United States Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure UK Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure France Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure China Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure India Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Prosthetic Joint Infections Treatment Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Prosthetic Joint Infections Treatment Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Prosthetic Joint Infections Treatment

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Prosthetic Joint Infections Treatment by Different Types from 2014 to 2026

    • Table Consumption Share of Prosthetic Joint Infections Treatment by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Fusidic acid

    • Figure Market Size and Growth Rate of Lefamulin Acetate

    • Figure Market Size and Growth Rate of MTF-101

    • Figure Market Size and Growth Rate of TNP-2092

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Prosthetic Joint Infections Treatment by Different End-Users from 2014 to 2026

    • Table Consumption Share of Prosthetic Joint Infections Treatment by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Others

    • Table Global Prosthetic Joint Infections Treatment Production by Major Regions

    • Table Global Prosthetic Joint Infections Treatment Production Share by Major Regions

    • Table Global Prosthetic Joint Infections Treatment Consumption by Major Regions

    • Table Global Prosthetic Joint Infections Treatment Consumption Share by Major Regions

    • Table North America Prosthetic Joint Infections Treatment Production, Import, Consumption and Export Analysis

    • Table Europe Prosthetic Joint Infections Treatment Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Prosthetic Joint Infections Treatment Production, Import, Consumption and Export Analysis

    • Table LAMEA Prosthetic Joint Infections Treatment Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Prosthetic Joint Infections Treatment Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Prosthetic Joint Infections Treatment Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Prosthetic Joint Infections Treatment Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Prosthetic Joint Infections Treatment Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Prosthetic Joint Infections Treatment Consumption by Major Countries from 2014 to 2026

    • Table North America Prosthetic Joint Infections Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Prosthetic Joint Infections Treatment Consumption Share by Major Countries in 2014

    • Figure North America Prosthetic Joint Infections Treatment Consumption Share by Major Countries in 2018

    • Figure North America Prosthetic Joint Infections Treatment Consumption Share by Major Countries in 2026

    • Figure United States Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Prosthetic Joint Infections Treatment Consumption by Types from 2014 to 2026

    • Table Europe Prosthetic Joint Infections Treatment Consumption Share by Types from 2014 to 2026

    • Table Europe Prosthetic Joint Infections Treatment Consumption by End-Users from 2014 to 2026

    • Table Europe Prosthetic Joint Infections Treatment Consumption Share by End-Users from 2014 to 2026

    • Table Europe Prosthetic Joint Infections Treatment Consumption by Major Countries from 2014 to 2026

    • Table Europe Prosthetic Joint Infections Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure France Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Prosthetic Joint Infections Treatment Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Prosthetic Joint Infections Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure China Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure India Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Prosthetic Joint Infections Treatment Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Prosthetic Joint Infections Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Prosthetic Joint Infections Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TenNor Therapeutics Ltd

    • Figure Sales and Growth Rate Analysis of TenNor Therapeutics Ltd

    • Figure Revenue and Market Share Analysis of TenNor Therapeutics Ltd

    • Table Product and Service Introduction of TenNor Therapeutics Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Motif Bio Plc

    • Figure Sales and Growth Rate Analysis of Motif Bio Plc

    • Figure Revenue and Market Share Analysis of Motif Bio Plc

    • Table Product and Service Introduction of Motif Bio Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Telephus Medical LLC

    • Figure Sales and Growth Rate Analysis of Telephus Medical LLC

    • Figure Revenue and Market Share Analysis of Telephus Medical LLC

    • Table Product and Service Introduction of Telephus Medical LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nabriva Therapeutics AG

    • Figure Sales and Growth Rate Analysis of Nabriva Therapeutics AG

    • Figure Revenue and Market Share Analysis of Nabriva Therapeutics AG

    • Table Product and Service Introduction of Nabriva Therapeutics AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cempra Inc

    • Figure Sales and Growth Rate Analysis of Cempra Inc

    • Figure Revenue and Market Share Analysis of Cempra Inc

    • Table Product and Service Introduction of Cempra Inc

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US